글로벌 림프부종 진단 시장 – 2029년까지의 산업 동향 및 예측

림프부종 진단 시장의 시장 분석 및 통찰력

림프부종 진단 시장은 2022년부터 2029년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 7.6%의 CAGR로 성장할 것으로 분석합니다.

림프부종은 기본적으로 만성 질환으로, 일반적으로 신체 조직의 어느 부위, 특히 팔과 다리가 붓는 것이 특징입니다. 림프계 손상으로 인해 발생합니다. 유방암 치료 후에도 발생할 수 있습니다. 수술 병력이나 림프절 손상을 포함한 다른 질환이 있는 경우 림프부종 진단은 종종 명확합니다.

암과 림프부종과 같은 만성 질환의 증가와 의료의 질에 대한 집중이 커진 것은 위에 언급된 예측 기간 동안 림프부종 진단 시장 성장을 주도하는 중요한 요인입니다. 또한, 새로운 진단 방법에 대한 투자와 혁신이 증가하고 중국, 인도, 브라질, 한국, 러시아와 같은 신흥국의 성장이 증가함에 따라 시장의 전반적인 성장이 높아졌습니다. 그러나 진단 영상 시스템의 높은 비용은 시장 성장을 방해합니다. 헬륨의 제한된 공급도 시장 성장을 제한합니다.

진단 영상 모달리티의 다양한 기술적 발전과 공공-민간 기관의 투자, 기금 및 보조금 증가는 시장에 수익성 있는 기회를 창출할 것으로 예상됩니다. 반면, 재생 진단 영상 시스템의 채택 증가는 시장 성장에 도전할 가능성이 있습니다.

This lymphedema diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research lymphedema diagnostics market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Lymphedema Diagnostics Market Scope and Market Size

Lymphedema diagnostics market is segmented on the basis of type, technology, disease type, treatment type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the lymphedema diagnostics market is segmented into primary and secondary.
• On the basis of technology, the lymphedema diagnostics market is segmented into lymphoscintigraphy, magnetic resonance imaging, ultrasound imaging, computed tomography, x-ray lymphography, bioimpedance analysis and near-infrared fluorescence imaging. Near-Infrared fluorescence imaging is further segmented into ICG lymphography and fluorescein sodium microlymphangiography. Lymphoscintigraphy segment holds the largest share due to the non-invasive nature and easy availability of the technology.
• The lymphedema diagnostics market has also been segmented on the basis of disease type into cancer, inflammatory diseases, cardiovascular diseases, and other diseases. Cancer segment holds the largest market share due to the rising awareness regarding the early diagnosis and occurrence of cancer related lymphedema.
• On the basis of treatment type, market is segmented into surgery, compression therapy and others.
• On the basis of type, the lymphedema diagnostics market is segmented into hospitals, diagnostic centres, research and academic institutes, others. Hospital segment accounted for the largest share in the market due to the adoption of minimally invasive procedure and the improvement of workflow efficiency in hospitals.

Lymphedema Diagnostics Market Country Level Analysis

Lymphedema diagnostics market is segmented on the basis of type, technology, disease type, treatment type and end user.

The countries covered in the lymphedema diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to the easy availability of the healthcare system. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the untapped growth opportunities in the region especially in, Japan, China, and India. The rising occurrence of chronic diseases and rising awareness about the early benefits.

The country section of the lymphedema diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Lymphedema diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for lymphedema diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the lymphedema diagnostics market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Lymphedema Diagnostics Market Share Analysis

Lymphedema diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to lymphedema diagnostics market.

림프부종 진단 시장 보고서에서 활동하는 주요 기업으로는 Shimadzu Corporation, Fluoptics, BIOCOMPRESSION SYSTEMS, Lohmann & Rauscher GmbH & Co. KG, Mego Afek ltd., SIGVARIS Group, Tactile Medical., PAUL HARTMANN AG, 3M, Convatec Inc., JUZO, SIGVARIS GROUP, Tactile Medical, BIOCOMPRESSION SYSTEMS, ThermoTek, Cardinal Health, Essity (BSN medical GmbH), Smith+Nephew HERANTIS PHARMA Plc, Stryker, Mitaka USA Inc., ImpediMed Limited 및 ImpediMed Inc. 등이 있습니다.

SKU-50683